Archive for August 21st, 2014
The technology to test and manage blood sugar results from smartphones took a big step this week. The Philosys group received 501K approval from the U.S. Food and Drug Administration (FDA) for the Gmate SMART Blood Glucose Monitoring System.
The Gmate SMART meter is not much bigger than a quarter. It connects to the headphone jack on the iPhone, iPod touch or iPad. It will use a free app to deliver blood glucose test results, without the use of an adapter or Bluetooth device.
The Gmate system will offer features such as goal setting, graphing, and the ability to email or text blood glucose test results directly to members of a diabetes care team.
Philosys is based in South Korea. Sales senior vice-president Mike Tickle said the company continues its efforts to be a technology leader for the diabetes mobile monitoring arena.
The American Diabetes Association (ADA) suggests talking to your doctor about whether you should be checking your blood glucose. People that may benefit from checking blood glucose include those:
- Taking insulin
- That are pregnant
- Having a hard time controlling blood glucose levels
- Having low blood glucose levels
- Having low blood glucose levels without the usual warning signs
- Have ketones from high blood glucose levels
The American Association of Diabetes Educators (AADE) lists Monitoring among its seven self-care behaviors for people living with diabetes. The actions are often seen as goals ensuring improvement and the best control of blood sugar levels.
The following video shows how the device is used and some of its features.
For more information, visit:
The use of a gout drug could help people living with diabetes avoid kidney problems. Allopurinol is the generic name of a drug used to treat gout. When high levels of uric acid gather in the body, gout is the result.
Several research groups have formed PERL or “Preventing Early Renal Function Loss in Diabetes.” They will study the effects of allopurinol on people with type 1 diabetes. The three-year study will test if the uric-acid cutting drug will also lower kidney damage.
New regimens have been introduced over the past 20 years. Blood sugar and blood pressure controlling drugs have not decreased the number of ESRD cases or end-stage renal disease.
Kidneys are made up of millions of small blood vessels. The vessels act as filters cleaning waste products from the blood. Diabetes can cause this filtering system to break down leading to kidney failure.
Consistently higher blood sugar levels make the kidneys filter too much blood. Over time, the filters start to leak and protein leaks into the urine. A person with ESRD would need a kidney transplant or start blood-filtering treatments using a dialysis machine for survival.
Allopurinol lowers the uric acid that causes gout. PERL researchers also hope uric acid reduction will protect kidneys when diabetes is present. The drug is on the market under the brand names Aloprim,Lopurin and Zyloprim.
The study will use subjects with type 1 diabetes, but it is hoped that one day the drug also could help those with type 2 diabetes.
For more on the study and kidney damage: